Guardant Health
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Diagnostics & Research
業務概覽 Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
公司地址 3100 Hanover Street, Palo Alto, CA, USA, 94304
電話號碼 +1 855 698-8887
傳真號碼 +1 888 974-4258
公司網頁 https://www.guardanthealth.com
員工數量 2506
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Darya Chudova Chief Technology Officer 美元 520.19K 28/04/2026
Ms. Terilyn Juarez Monroe Chief People Officer -- 28/04/2026
Mr. John G. Saia Chief Legal Officer and Corporate Secretary 美元 527.12K 28/04/2026
Mr. Michael Brian Bell Chief Financial Officer and Principal Accounting Officer 美元 566.15K 28/04/2026
Dr. Helmy Eltoukhy, PhD Co-Chief Executive Officer and Chairman of the Board 美元 1 28/04/2026
Mr. Kumud Kalia Chief Information Officer -- 28/04/2026
Dr. AmirAli Talasaz, PhD Co-Chief Executive Officer and Director 美元 1 28/04/2026
Mr. Christopher Freeman Chief Commercial Officer -- 28/04/2026
Dr. Craig Eagle, M.D. Chief Medical Officer 美元 576.15K 27/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Ian T. Clark Lead Independent Director 28/04/2026
Mr. Musa Tariq Independent Director 28/04/2026
Ms. Myrtle S. Potter Independent Director 28/04/2026
Ms. Vijaya Gadde Independent Director 28/04/2026
Dr. Manuel Hidalgo Medina, M.D.,PhD Independent Director 28/04/2026
Mr. Alex M. Azar,II Independent Director 28/04/2026
Mr. Roberto A. Mignone Independent Director 28/04/2026
Dr. Helmy Eltoukhy, PhD Co-Chief Executive Officer and Chairman of the Board 28/04/2026
Dr. AmirAli Talasaz, PhD Co-Chief Executive Officer and Director 28/04/2026
Ms. Meghan V. Joyce Independent Director 28/04/2026
Mr. Steven E. Krognes, M.B.A. Independent Director 28/04/2026
 
所屬ETF (更新日期: 02/05/2026 02:17)
代號 名稱 佔比% ▼ 持有日期
FDMOFidelity Momentum Factor ETF<0.000001%20/02/2026
FEACFidelity Enhanced U.S. All-Cap Eq ETF<0.000001%15/04/2026
FFNDOne Global ETF<0.000001%31/10/2025
FFTYCapForce IBD® 50 ETF<0.000001%09/02/2026
FMDEFidelity Enhanced Mid Cap ETF<0.000001%23/12/2025
HKNDHumankind US Stock ETF<0.000001%24/11/2025
HYPGolden Eagle Dynamic Hypergrowth ETF<0.000001%03/02/2026
IALTiShares Systematic Alternatives Actv ETF<0.000001%12/12/2025
JHSCJHancock Multifactor Small Cap ETF<0.000001%16/03/2026
LITLSimplify Piper Sandler USSm-CpPLUSIncETF<0.000001%30/09/2025
NXTISimplify Next Intangible Core Index ETF<0.000001%16/03/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF<0.000001%08/04/2026
PJFMPGIM Jennison Focused Mid-Cap ETF<0.000001%18/02/2026
PTHInvesco Dorsey Wright Healthcare MomtETF<0.000001%01/04/2026
QMOMAlpha Architect US Quantitative Momt ETF<0.000001%31/03/2026
QQJGInvesco ESG NASDAQ Next Gen 100 ETF<0.000001%20/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF<0.000001%04/12/2025
SMMDiShares Russell 2500 ETF<0.000001%06/03/2026
STXKStrive Small-Cap ETF<0.000001%12/03/2026
TMATMain Thematic Innovation ETF<0.000001%28/01/2026
  1    2    3    4    5    6    7   8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.